schliessen

Filtern

 

Bibliotheken

1.

Paying a high price for cancer drugs
by The Lancet

Lancet (London, England), 01 August 2015, Vol.386(9992), pp.404

2.

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
by Sánchez-Martínez, Concepción

Bioorganic & medicinal chemistry letters, 01 September 2015, Vol.25(17), pp.3420-35

3.

Identification of amino acid appended acridines as potential leads to anti-cancer drugs.
by Singh, Palwinder

Bioorganic & medicinal chemistry letters, September 15, 2015, Vol.25(18), pp.3854-3858

12.

Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study.
by Pivot, Xavier

European journal of cancer (Oxford, England : 1990), September 2015, Vol.51(13), pp.1660-1666

13.

Exposure to anticancer drugs can result in transgenerational genomic instability in mice.
by Glen, Colin D

Proceedings of the National Academy of Sciences of the United States of America, February 21, 2012, Vol.109(8), pp.2984-2988

14.

Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer.
by Wang, Yuxia

Biochemical and biophysical research communications, October 23, 2015, Vol.466(3), pp.362-368

15.

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current.
by Sittl, Ruth

Proceedings of the National Academy of Sciences of the United States of America, April 24, 2012, Vol.109(17), pp.6704-6709

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 349.941 Hits